# Cradle vs Insight

Cradle records 16,993 monthly visits with -22.3% month-over-month growth and Contact for Pricing pricing. Insight records 2,761 monthly visits with -2.7% growth and Free pricing.

| Metric | [Cradle](https://openaitools.app/tool/cradle) | [Insight](https://openaitools.app/tool/insight) |
| :--- | :--- | :--- |
| Website URL | https://cradle.bio | https://insightai.dev |
| Categories | AI Design Generator, AI Healthcare, AI Research Tool, AI Productivity Tools | AI Research Tool, AI Healthcare, AI Assistant, AI Article Summarizer |
| Pricing Model | Contact for Pricing | Free |
| Monthly Visits | 16,993 | 2,761 |
| MoM Growth Rate | -22.3% | -2.7% |
| Primary Market | Netherlands | United States |
| Direct Visits | 6,214 | 1,088 |
| Review Score | 4.5 | 4.4 |
| Saved Count | 2 | 2 |
| Supported Platforms | Website | Website |

## Cradle

Cradle is a protein engineering platform that applies machine learning to the design and optimization of proteins. Instead of optimizing one property at a time, teams use Cradle to work on potency, specificity, expression, thermostability, and manufacturability simultaneously — compressing the number of experimental rounds needed to reach a candidate that meets a target profile.

The platform covers a broad range of protein classes, including antibodies for ADC and multispecific formats, enzymes that need to hold up in hostile conditions, vaccine antigens that must keep their shape outside the lab, and peptides that need potency within tight constraints even from small datasets. It works whether or not a starting protein already exists, and it learns from the customer's own experimental data, including results from previous failed campaigns, so each design round is better informed than the last.

Cradle is positioned for multiple roles in an organization: experimental scientists get point-and-click candidate design and optimization; computational scientists get the same functionality exposed through an API for scripting and integration; and R&D leadership gains a compounding advantage from every experiment their teams have run. Security is a stated priority, with ISO 27001 and SOC 2 Type II certification and hosting on Google Cloud. Pricing is not published — interested teams discuss their project with Cradle to get terms.

**Pricing & Plans:** Pricing is not publicly listed. Cradle uses a contact-for-pricing model where teams discuss their project and program scope directly with the company; a licensing track and API access are offered alongside the core platform.

- **De novo protein design:** Start from a target or your own sequence and have Cradle design an optimized plate of candidates informed by your data and domain knowledge.
- **Parallel multi-property optimization:** Improve efficacy, developability, and manufacturability in parallel rather than one property at a time, compressing time to a target profile.
- **Closed-loop learning from experimental data:** Every round incorporates results from the previous one, so experimental data compounds across campaigns and prior failed programs stay useful.
- **Full API access:** Everything in the web application is exposed through the API, so computational teams can script campaigns and wire Cradle into existing pipelines.
- **Enterprise-grade security and compliance:** ISO 27001 and SOC 2 Type II certified, hosted on Google Cloud with data isolation and continuous monitoring for enterprise deployments.

**Strengths:** Optimizes multiple protein properties in parallel rather than sequentially, which can cut the number of experimental rounds; Learns from a customer's own experimental data, including negative and failed results; Covers antibodies, enzymes, vaccines, and peptides in one platform; Full API parity with the web app supports computational and automated workflows

**Limitations:** No self-serve trial or published pricing, so evaluation requires a sales conversation; Requires in-house experimental capability to generate the assay data that drives the models; Cost and onboarding are geared to organizations rather than individual researchers

[Profile (Markdown)](https://openaitools.app/tool/cradle.md)

## Insight

Insight was created to remove one of the least rewarding parts of research: reading. Its PubMed feature searches across tens of millions of peer-reviewed biomedical articles, using language models to produce a one-click scientific summary instead of a list of citations to chase. Researchers can point it at a question and get a structured starting point within seconds.

Beyond summarization, the platform covers hypothesis generation and experimental design, exporting designs as a PDF report. It also integrates specialized data: MyVariant brings in hundreds of millions of human variants, MyGene covers millions of genes across tens of thousands of species, and NIH RePORTER and ClinicalTrials.gov supply insight into funded projects and ongoing or completed trials. A separate high-throughput discovery module aims at target, biomarker, and prognostic marker identification.

Insight is positioned as a free tool, with an optional donation channel to support the team. Its outputs are grounded in peer-reviewed sources, but the platform is a research accelerator rather than a clinical decision tool, so conclusions should still be validated by domain experts.

**Pricing & Plans:** Insight is free to use. The site asks visitors to try the tool and offers an optional donation link to support the mission; a waitlist exists for the high-throughput discovery module.

- **One-click scientific summaries:** Searches over 36 million peer-reviewed biomedical articles across roughly 30,000 journals and condenses findings into readable summaries.
- **Hypothesis generation:** Turns a research question into candidate hypotheses to explore, saving the blank-page phase of a study.
- **Experimental design export:** Drafts experimental designs that can be exported as a PDF report for review or planning.
- **Gene and variant data:** Integrates MyGene and MyVariant for gene and mutation lookups across millions of genes and human variants.
- **Grants and trials:** Connects NIH RePORTER and ClinicalTrials.gov so users can see funded projects and ongoing or completed clinical trials.

**Strengths:** Free to use with no cost barrier; Grounded in peer-reviewed and official biomedical data sources; Covers the full path from literature to hypothesis to design; Integrated gene, variant, trial, and grant data in one place

**Limitations:** AI-generated summaries still need expert verification before use; Some advanced discovery features are waitlisted; Interface is utilitarian and aimed at researchers rather than casual users

[Profile (Markdown)](https://openaitools.app/tool/insight.md)

## Frequently Asked Questions

### How do Cradle and Insight compare in monthly traffic?

Cradle has 16,993 monthly visits, while Insight has 2,761. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Cradle has a month-over-month growth rate of -22.3%; Insight has -2.7%.

### How does pricing compare?

Cradle: Contact for Pricing. Pricing is not publicly listed. Cradle uses a contact-for-pricing model where teams discuss their project and program scope directly with the company; a licensing track and API access are offered alongside the core platform. Insight: Free. Insight is free to use. The site asks visitors to try the tool and offers an optional donation link to support the mission; a waitlist exists for the high-throughput discovery module.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | A free, AI-powered academic search engine for 240M+ papers across every scientific field | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 2 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | AI academic search engine for peer-reviewed science | [.md](https://openaitools.app/tool/consensus.md) |
| 3 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | AI research platform for reading, understanding and writing scientific papers | [.md](https://openaitools.app/tool/scispace.md) |
| 4 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | AI research assistant for evidence-based literature review and synthesis | [.md](https://openaitools.app/tool/elicit.md) |
| 5 | [Rayyan](https://openaitools.app/tool/rayyan) | 1,116,437 | +7.9% | Freemium | AI-assisted systematic review software for screening, extraction, and evidence synthesis at scale | [.md](https://openaitools.app/tool/rayyan.md) |
| 6 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | AI answers grounded in 300M+ scholarly full texts | [.md](https://openaitools.app/tool/scite.md) |
| 7 | [Connected Papers](https://openaitools.app/tool/connected-papers) | 750,576 | +3.1% | Freemium | Explore the academic literature as a visual graph of related papers | [.md](https://openaitools.app/tool/connected-papers.md) |
| 8 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 9 | [Paperguide](https://openaitools.app/tool/paperguide) | 371,972 | -2.9% | Freemium | AI-native workspace for literature reviews and auditable systematic reviews | [.md](https://openaitools.app/tool/paperguide.md) |
| 10 | [Uizard](https://openaitools.app/tool/uizard) | 294,618 | -15% | Freemium | AI-powered UI design and prototyping for product teams | [.md](https://openaitools.app/tool/uizard.md) |

---
Source: https://openaitools.app/compare/cradle-vs-insight

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)